Short interfering RNA-directed inhibition of hepatitis B virus replication.
about
MicroRNAs Expressed during Viral Infection: Biomarker Potential and Therapeutic ConsiderationsHarnessing the RNA interference pathway to advance treatment and prevention of hepatocellular carcinomaSmall RNAs with imperfect match to endogenous mRNA repress translation. Implications for off-target activity of small inhibitory RNA in mammalian cells.Short interfering RNA (siRNA) as a novel therapeutic.RNA Interference inhibits hepatitis B virus of different genotypes in vitro and in vivoClearance of hepatitis B virus from the liver of transgenic mice by short hairpin RNAsInhibition of coxsackievirus B3 replication by small interfering RNAs requires perfect sequence match in the central region of the viral positive strand.Enhanced antiviral and antifibrotic effects of short hairpin RNAs targeting HBV and TGF-β in HBV-persistent mice.Progress in the use of RNA interference as a therapy for chronic hepatitis B virus infection.Decrease of murine cytomegalovirus-induced retinitis by intravenous delivery of immediate early protein-3-specific siRNA.Genomic analysis of anti-hepatitis B virus (HBV) activity by small interfering RNA and lamivudine in stable HBV-producing cells.siRNA therapeutics: big potential from small RNAs.Combination of small interfering RNAs mediates greater inhibition of human hepatitis B virus replication and antigen expression.The effect of murine cytomegalovirus IE-3 specific shRNA is dependent on intragenic target site due to multiple transcription initiation sitesTherapeutic potential of retroviral RNAi vectors.Development of gene-specific double-stranded RNA drugs.RNA interference--small RNAs effectively fight viral hepatitis.RNAi, a new therapeutic strategy against viral infection.Exploiting the RNA interference pathway to counter hepatitis B virus replication.Quantifying anti-HBV effect of targeted ribonuclease by real-time fluorescent PCR.Effect of vector-expressed siRNA on HBV replication in hepatoblastoma cells.The therapeutic potential of RNA interference.RNAi for treating hepatitis B viral infection.Molecular functions and biological roles of hepatitis B virus x protein.Opportunities for treating chronic hepatitis B and C virus infection using RNA interference.RNA interference and antiviral therapy.Transgenically mediated shRNAs targeting conserved regions of foot-and-mouth disease virus provide heritable resistance in porcine cell lines and suckling mice.Emerging drugs for respiratory syncytial virus infection.Therapeutic potential of adenoviral vectors for delivery of expressed RNAi activators.Countering hepatitis B virus infection using RNAi: how far are we from the clinic?Recent advances in developing nucleic acid-based HBV therapy.Gene therapeutic approaches to inhibit hepatitis B virus replication.Polymers in the Delivery of siRNA for the Treatment of Virus Infections.Screening effective short interfering RNA/short hairpin RNA for inhibition of human astrovirus ORF2 gene expression in cultured cells.Inhibition of Hazara nairovirus replication by small interfering RNAs and their combination with ribavirin.Inhibition of vaccinia virus replication by two small interfering RNAs targeting B1R and G7L genes and their synergistic combination with cidofovir.Vector design for liver-specific expression of multiple interfering RNAs that target hepatitis B virus transcripts.An RNAi-based high-throughput screening assay to identify small molecule inhibitors of hepatitis B virus replication.RNA interference inhibits hepatitis B virus gene expression and replication in HepG2-N10 cells.Cost-effective method of siRNA preparation and its application to inhibit hepatitis B virus replication in HepG2 cells.
P2860
Q26773183-2D8CFC73-2DCF-4967-AF99-01B2BEF04D25Q27488744-9FA350E7-8574-474B-A27A-552EDB383FA2Q30311189-B337688B-E096-4464-9A62-77372E21D515Q33243420-BEC86EC0-5388-4B54-BD36-3A738D3EB1D1Q33653027-7A243A7F-DBD7-43A2-B9BC-04B2114536BDQ33756729-38F0FABB-6E56-4EFF-B19A-63D73DF0D085Q33781261-F7C0BED4-0D37-4293-99A1-1A56AED31CEAQ33819100-3CC6853A-B139-4051-AE9C-83B60499F81AQ33865784-61FE0EE9-34F7-43BA-A350-15477463B395Q33872385-72938EA8-D75D-4A96-A545-9DA3BE86904DQ34123971-7649A541-CEC5-4B5E-A375-16139561A9A5Q34360881-73C979D5-49E4-40CF-92A3-ADA6F4A4326AQ34425073-9E94F1F9-7C0B-40CF-AF5A-108BF2BDAC20Q35338935-55B7EFB1-6420-4808-9BC8-01695B85EE58Q35684854-AF3C20C2-31B6-4856-9418-D557576E9910Q35932393-87691CF1-655F-4558-8779-DCC876010D6BQ35964876-2A9750BD-0CDC-4D0B-8B04-D4FD51D8BD21Q35996300-84FE28F6-00CC-4D9D-A93C-69A721EF02DDQ36033368-801C67A2-FB86-46D9-BC90-723D1916FFF5Q36065628-884C0A2E-6C8D-4009-BAB8-96F99A42C3D6Q36065871-DCF47812-D345-428B-B816-C35A347120E8Q36237868-09866C50-62BF-4293-88BF-0C286ECF2BD9Q36412870-DCF6F5E6-F9D0-4F71-A4B7-6994CBFA53D2Q36597687-9AE91FCE-7E70-4536-AEA4-94AC3D1FA363Q36852196-0C391090-61F0-4A22-8C51-0D23FAF0E28DQ36944914-DA803068-882D-4F97-A5EE-FFAD7760CD85Q37027961-6271895C-DA9E-4E38-B86C-87C98ADD7C97Q37250650-641C263F-CCDC-4A56-8440-2CEAC96CF49EQ37809086-F41F0BF5-F354-44B0-A1EC-FBE17D2FD3BCQ37931159-29EBBFED-9A79-4D59-8D3C-63FEF65CFFB2Q38160538-510C5D0A-6C46-49A1-86D3-696856F2988AQ38366585-84CE4BE3-C36D-4023-95DF-C517AC8B71FFQ38889573-FA3494E5-1CCA-4106-B159-91C43606FD08Q39070063-96C278CA-473F-4A32-9C20-2185FA25BD3AQ39539133-64E90C15-C78A-4BBF-8025-5631401E2BE6Q39869286-DC5339AF-DA6B-4BB5-A24A-0F7514CB85A6Q39979308-5605B238-2E3D-4987-9676-D62EAD862835Q40171806-7D3A8BE3-E1C6-436F-B4E1-6D5C866D71B5Q40217527-EF75FB0B-29AB-46C4-986A-E45CFA626767Q40447828-F570C042-FBBD-4AE1-BC63-737E01B74A9A
P2860
Short interfering RNA-directed inhibition of hepatitis B virus replication.
description
2003 nî lūn-bûn
@nan
2003年の論文
@ja
2003年学术文章
@wuu
2003年学术文章
@zh
2003年学术文章
@zh-cn
2003年学术文章
@zh-hans
2003年学术文章
@zh-my
2003年学术文章
@zh-sg
2003年學術文章
@yue
2003年學術文章
@zh-hant
name
Short interfering RNA-directed inhibition of hepatitis B virus replication.
@en
Short interfering RNA-directed inhibition of hepatitis B virus replication.
@nl
type
label
Short interfering RNA-directed inhibition of hepatitis B virus replication.
@en
Short interfering RNA-directed inhibition of hepatitis B virus replication.
@nl
prefLabel
Short interfering RNA-directed inhibition of hepatitis B virus replication.
@en
Short interfering RNA-directed inhibition of hepatitis B virus replication.
@nl
P2093
P2860
P1433
P1476
Short interfering RNA-directed inhibition of hepatitis B virus replication.
@en
P2093
Hiroki Ishikawa
Katsumi Eguchi
Kazuhiko Nakao
Keisuke Hamasaki
Kojiro Matsumoto
Tatsuki Ichikawa
P2860
P356
10.1016/S0014-5793(03)00400-9
P407
P577
2003-05-01T00:00:00Z